It is one of the major public health concerns in low- and middle-income countries. Complete avoidance of exposure to the insect bite is the best way to prevent vector borne transmission. On the other hand, eradication of the causative insect vectors by adequate vector control measures is considered as the mainstay to prevent the spread of infections. Vector borne diseases impose a greater disease burden across the globe. Therefore, promoting indigenous research at a global level to find novel diagnostic and therapeutic options to contain the present disease incidence and tackle the future infections.
Ongoing Research On Vector Borne Diseases:
-
Vaccine Development: Developing vaccines for diseases like dengue and malaria remains a top priority. Researchers are working on improving vaccine efficacy and creating long-lasting immunity against vector borne pathogens. For example, significant progress has been made in developing the RTS,S vaccine for malaria.
-
Diagnostic Advancements: Early and accurate diagnosis is vital for controlling the spread of vector borne diseases. Current research is focused on improving diagnostic methods, such as point-of-care diagnostic tools and rapid antigen tests, which enable timely detection and treatment of diseases like Zika and Lyme disease.
-
Vector Control Strategies: Research continues into new and innovative ways to control insect vectors. Genetic modification of mosquitoes to make them incapable of transmitting diseases, as well as environmental interventions like insecticide-treated nets and improved sanitation, are being explored to reduce the spread of mosquito borne diseases.
-
Therapeutic Options: Discovering new drugs to combat resistant strains of malaria and other vector borne diseases is another research priority. There is ongoing work on identifying novel therapeutic compounds and improving existing drug regimens to tackle resistance issues.
-
Epidemiology and Surveillance: Researchers are studying the epidemiological patterns of vector borne diseases to predict future outbreaks. These studies help in understanding transmission dynamics and developing early warning systems to mitigate the impact of future infections.
Insight to the Vector Borne Diseases Biospecimens We Offer:
Central BioHub defines the quickest pathway to reach the matching research specimens you are searching for. With our online human biospecimen marketplace, we help global biomedical researchers easily procure required samples within no time. Central BioHub presents you with a wide range of high-quality human biospecimens for major vector borne diseases or mosquito borne diseases such as Malaria samples, Dengue, Lyme disease, and more. As a young scientific company, Central BioHub offers no compromise on the quality of biospecimens. Therefore, mosquito borne diseases samples such as human serum, plasma, urine, saliva, and other body fluids are well preserved in perfect condition devoid of cross-contamination at our supplier’s biobank. Moreover, we provide samples that are well annotated, clinically graded, and fit to carry out successful research. Customer satisfaction and quality services are our priorities. Reach out to us for ordering vector borne diseases samples or clinical research samples.
Explore advanced search options to order vector borne disease samples by clicking on Clinical Diagnosis, ICD-10-CM codes, Matrix, and Laboratory Parameters.